“…Through AE, a term first coined in respect to mtDNA gene expression in 1986 (Gearing and Nagley, 1986;Grasso et al, 1991), this phenomenon has led to speculation, experimentation, and subsequent mouse models . AE as a potential gene therapy was postulated as a strategy for either circumventing or correcting diseases involving mtDNA mutation (DiMauro and Mancuso, 2007;Kyriakouli et al, 2008) and as a means to overcome the absence of animal models reflecting mtDNA mutations in human disease (see .…”